(2)
The Corporation intends to install a second shaping module at the Shaping Demonstration Plant.
(3)
Covers 12 months of the operating costs of the Shaping Demonstration Plant, namely energy, consumables and manpower costs.
(4)
Covers 12 months of the operating costs of the Purification Demonstration Plant, expected to be incurred, for the period following the commissioning anticipated for mid-2021, namely the Olin facility rental, energy, consumables and manpower costs.
(5)
Covers the capital cost to build the 2,000 tpa capacity Coating Demonstration Plant that is scheduled to be commissioned in Q1-2022.
(6)
Covers the FEL-2 and FEL-3 analysis costs with respect to the LiB Anode Plant project.
(7)
Covers general working capital and corporate expense needs, including (i) general and administrative expenses, sales and marketing expenses, (ii) expenses associated with the deployment of employee training and business opportunity promotion programs, (iii) expenses associated with the integration of the Upper Matawinie communities, and (iv) expenses associated with marketing and qualification process for graphite concentrate and spherical graphite for international customers.
(8)
Includes the commitment payments for equipment with anticipated delivery lead times longer than approximately six months, such as filter press, crushing station, mills, substation and electrical houses.
(9)
Includes tree clearing, access road construction, general civil work and underground services.
If the Over-Allotment Option is exercised in full, the Corporation will receive additional net proceeds of US$7,323,750 after deducting the Underwriters’ Fee only. If the Private Placement Option is exercised in full, the Corporation will receive additional net proceeds of US$1,968,750. The net proceeds from the exercise of the Over-Allotment Option and the Private Placement Option, if any, are expected to be applied towards the general working capital and corporate expense needs of the Corporation.
The Corporation intends to use the proceeds from the Offering and the Private Placement as described above, but such use will depend on its operating needs, the implementation of its strategic plan and changes in the prevalent business environment and operating conditions. The allocation outlined above represents the Corporation’s current intention with respect to its use of proceeds from the Offering and the Private Placement and other available funds based on current knowledge and planning by management of the Corporation. There may be circumstances where, for sound business reasons, the Corporation may reallocate the use of proceeds of the Offering and the Private Placement. See “Risk Factors — The Corporation may use the proceeds from the sale of the Offered Shares for purposes other than those set out in this Prospectus Supplement” and “Risk Factors — It is Uncertain Whether the Private Placement Will be Completed” in this Prospectus Supplement, and “Risk Factors — Risks Related to An Offering of Securities — Discretion in the Use of Proceeds” in the Prospectus.
Operating Cash Flow (in thousands of dollars)
The Corporation has no history of revenues from its operating activities. The Corporation’s cash and cash equivalents amounted to $34,073, $4,520 and $4,077 as at March 31, 2021, as at December 31, 2020, and as at December 31, 2019, respectively. During the three month-period ended March 31, 2021 and the fiscal years ended December 31, 2020 and December 31, 2019, the Corporation had negative cash flow usage from operating activities of $10,190, $18,049 and $18,654, respectively. For the three month-period ended March 31, 2021, the Corporation had an average monthly cash expenditure rate of approximately $3,793 per month, including addition to property, plant and equipment, intangible assets, deposit to suppliers and all operating expenses and development costs not covered by grants. For the three month-period ended March 31, 2021, the Corporation recorded a net loss and comprehensive loss of $7,444. As of March 31, 2021, the Corporation had current liabilities of $11,979 and an outstanding convertible bond with a principal of $15,000 to be repaid at the latest on August 28, 2023. For the fiscal year ended December 31, 2020, the Corporation had an average monthly cash expenditure rate of approximately $1,559 per month, including addition to property, plant and equipment, intangible assets, deposit to suppliers and all operating expenses and development costs not covered by grants. The Corporation anticipates it will continue to have negative cash flow from operating activities in future periods at least until commercial production is achieved at the Matawinie Mine and/or the LiB Anode Plant. To the extent that the Corporation has negative operating cash flows in future periods, the Corporation may need to allocate a portion of its existing working capital to fund such negative cash flow or the Corporation may adjust the expenditure rate to preserve liquidity.
As at March 31, 2021, the Corporation’s cash and cash equivalents and working capital amounted to $34,073 and to $29,681, respectively. As at May 31, 2021, the Corporation’s cash and cash equivalents and working capital amounted to $25,653 and to $21,972, respectively. Together with the contemplated Offering,